|
1
|
Beckmann AM, Matsumoto I and Wilce PA:
AP-1 and Egr DNA-binding activities are increased in rat brain
during ethanol withdrawal. J Neurochem. 69:306–314. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Skerka C, Decker EL and Zipfel PF:
Coordinate expression and distinct DNA-Binding characteristics of
the four EGR-zinc finger proteins in jurkat T lymphocytes.
Immunobiology. 198:179–191. 1997. View Article : Google Scholar
|
|
3
|
Chavrier P, Zerial M, Lemaire P, Almendral
J, Bravo R and Charnay P: A gene encoding a protein with zinc
fingers is activated during G0/G1 transition in cultured cells.
EMBO J. 7:29–35. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Joseph LJ, Le Beau MM, Jamieson GA,
Acharya S, Shows TB, Rowley JD and Sukhatme VP: Molecular cloning,
sequencing, and mapping of EGR2, a human early growth response gene
encoding a protein with 'zinc-binding finger' structure. Proc Natl
Acad Sci USA. 85:7164–7168. 1988. View Article : Google Scholar
|
|
5
|
Cao X, Mahendran R, Guy GR and Tan YH:
Detection and characterization of cellular EGR-1 binding to its
recognition site. J Biol Chem. 268:16949–16957. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Myung E, Park YL, Kim N, Chung CY, Park
HB, Park HC, Myung DS, Kim JS, Cho SB, Lee WS and Joo YE:
Expression of early growth response-1 in human gastric cancer and
its relationship with tumor cell behaviors and prognosis. Pathol
Res Pract. 209:692–699. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li L, Ameri AH, Wang S, Jansson KH, Casey
OM, Yang Q, Beshiri ML, Fang L, Lake RG, Agarwal S, et al: EGR1
regulates angiogenic and osteoclastogenic factors in prostate
cancer and promotes metastasis. Oncogene. 38:6241–6255. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schmidt K, Carroll JS, Yee E, Thomas DD,
Wert-Lamas L, Neier SC, Sheynkman G, Ritz J and Novina CD: The
lncRNA SLNCR recruits the androgen receptor to EGR1-Bound genes in
melanoma and inhibits expression of tumor suppressor p21. Cell
Reports. 27:2493–2507.e4. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calogero A, Arcella A, De Gregorio G,
Porcellini A, Mercola D, Liu C, Lombari V, Zani M, Giannini G,
Gagliardi FM, et al: The early growth response gene EGR-1 behaves
as a suppressor gene that is down-regulated independent of ARF/Mdm2
but not p53 alterations in fresh human gliomas. Clin Cancer Res.
7:2788–2796. 2001.PubMed/NCBI
|
|
10
|
Damm F, Mylonas E, Cosson A, Yoshida K,
Della Valle V, Mouly E, Diop M, Scourzic L, Shiraishi Y, Chiba K,
et al: Acquired initiating mutations in early hematopoietic cells
of CLL patients. Cancer Discov. 4:1088–1101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oakes CC, Seifert M, Assenov Y, Gu L,
Przekopowitz M, Ruppert AS, Wang Q, Imbusch CD, Serva A, Koser SD,
et al: DNA methylation dynamics during B cell maturation underlie a
continuum of disease phenotypes in chronic lymphocytic leukemia.
Nat Genet. 48:253–264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ying Y, Ma X, Fang J, Chen S, Wang W, Li
J, Xie H, Wu J, Xie B, Liu B, et al: EGR2-mediated regulation of
m6A reader IGF2BP proteins drive RCC tumorigenesis and metastasis
via enhancing S1PR3 mRNA stabilization. Cell Death Dis. 12:7502021.
View Article : Google Scholar :
|
|
13
|
Xiao H, Huang X, Chen H, Zheng Y, Liu W,
Chen J, Wei R, Lin M, Wang Q and Zhuang W: Establishment of a SUMO
pathway related gene signature for predicting prognosis,
chemotherapy response and investigating the role of EGR2 in bladder
cancer. J Cancer. 15:3841–3856. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schwachtgen JL, Houston P, Campbell C,
Sukhatme V and Braddock M: Fluid shear stress activation of egr-1
transcription in cultured human endothelial and epithelial cells is
mediated via the extracellular signal-related kinase 1/2
mitogen-activated protein kinase pathway. J Clin Invest.
101:2540–2549. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim JH, Jeong IY, Lim YH, Lee YH and Shin
SY: Estrogen receptor β stimulates Egr-1 transcription via
MEK1/Erk/Elk-1 cascade in C6 glioma cells. BMB Rep. 44:452–457.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Masle-Farquhar E, Peters TJ, Miosge LA,
Parish IA, Weigel C, Oakes CC, Reed JH and Goodnow CC: Uncontrolled
CD21low age-associated and B1 B cell accumulation caused by failure
of an EGR2/3 tolerance checkpoint. Cell Rep. 38:1102592022.
View Article : Google Scholar
|
|
17
|
Veremeyko T, Yung AWY, Anthony DC,
Strekalova T and Ponomarev ED: Corrigendum: Early growth response
Gene-2 is essential for M1 and M2 macrophage activation and
plasticity by modulation of the transcription factor CEBPβ. Front
Immunol. 9:29232018. View Article : Google Scholar
|
|
18
|
Zhang S, Xia C, Xu C, Liu J, Zhu H, Yang
Y, Xu F, Zhao J, Chang Y and Zhao Q: Early growth response 3
inhibits growth of hepatocellular carcinoma cells via upregulation
of Fas ligand. Int J Oncol. 50:805–814. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shin SH, Kim I, Lee JE, Lee M and Park JW:
Loss of EGR3 is an independent risk factor for metastatic
progression in prostate cancer. Oncogene. 39:5839–5854. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie Y, Han X, Yu J, Yuan M, Yan Y, Qin J,
Lan L and Wang Y: EGR3 and estrone are involved in the tamoxifen
resistance and progression of breast cancer. J Cancer Res Clin
Oncol. 149:18103–18117. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Inoue A, Omoto Y, Yamaguchi Y, Kiyama R
and Hayashi S: Transcription factor EGR3 is involved in the
estrogen-signaling pathway in breast cancer cells. J Mol
Endocrinol. 32:649–661. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hicks HM, Pozdeyev N, Sams SB, Pugazhenthi
U, Bales ES, Hofmann MC, McKenna LR and Schweppe RE: Fibronectin
contributes to a BRAF Inhibitor-driven invasive phenotype in
thyroid cancer through EGR1, which can be blocked by inhibition of
ERK1/2. Mol Cancer Res. 21:867–880. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hua Y, Wang H, Ye Z, Zheng D and Zhang X:
An integrated pan-cancer analysis of identifying biomarkers about
the EGR family genes in human carcinomas. Comput Biol Med.
148:1058892022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Joyce JA and Fearon DT: T cell exclusion,
immune privilege, and the tumor microenvironment. Science.
348:74–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Quail DF and Joyce JA: The
microenvironmental landscape of brain tumors. Cancer Cell.
31:326–341. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
LeBlanc SE, Ward RM and Svaren J:
Neuropathy-associated Egr2 mutants disrupt cooperative activation
of myelin protein zero by Egr2 and Sox10. Mol Cell Biol.
27:3521–3529. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Collins S, Lutz MA, Zarek PE, Anders RA,
Kersh GJ and Powell JD: Opposing regulation of T cell function by
Egr-1/NAB2 and Egr-2/Egr-3. Eur J Immunol. 38:528–536. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Samakai E, Hooper R, Martin KA, Shmurak M,
Zhang Y, Kappes DJ, Tempera I and Soboloff J: Novel STIM1-dependent
control of Ca2+ clearance regulates NFAT activity during
T-cell activation. FASEB J. 30:3878–3886. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ge Y, Liu H, Huang W, Zhu H, Zong D and He
X: Immunoinhibitory effects of hypoxia-driven reprogramming of
EGR1hi and EGR3 positive B cells in the nasopharyngeal carcinoma
microenvironment. Oral Oncol. 158:1069992024. View Article : Google Scholar
|
|
30
|
Veremeyko T, Yung AWY, Anthony DC,
Strekalova T and Ponomarev ED: Early growth response Gene-2 is
essential for M1 and M2 macrophage activation and plasticity by
modulation of the transcription factor CEBPβ. Front Immunol.
9:25152018. View Article : Google Scholar
|
|
31
|
Thiel G, Müller I and Rössler OG:
Expression, signaling and function of Egr transcription factors in
pancreatic β-cells and insulin-responsive tissues. Mol Cell
Endocrinol. 388:10–19. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Srinivasan R, Mager GM, Ward RM, Mayer J
and Svaren J: NAB2 Represses Transcription by Interacting with the
CHD4 Subunit of the Nucleosome Remodeling and Deacetylase (NuRD)
Complex. J Biol Chem. 281:15129–15137. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Silverman ES and Collins T: Pathways of
Egr-1-mediated gene transcription in vascular biology. Am J Pathol.
154:665–670. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gregg J and Fraizer G: Transcriptional
regulation of EGR1 by EGF and the ERK signaling pathway in prostate
cancer cells. Genes Cancer. 2:900–909. 2011. View Article : Google Scholar
|
|
35
|
Cavigelli M, Dolfi F, Claret FX and Karin
M: Induction of c-fos expression through JNK-mediated TCF/Elk-1
phosphorylation. EMBO J. 14:5957–5964. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cabodi S, Morello V, Masi A, Cicchi R,
Broggio C, Distefano P, Brunelli E, Silengo L, Pavone F, Arcangeli,
et al: Convergence of integrins and EGF receptor signaling via
PI3K/Akt/FoxO pathway in early gene Egr-1 expression. J Cell
Physiol. 218:294–303. 2009. View Article : Google Scholar
|
|
37
|
Ivanova D, Dirks A, Montenegro-Venegas C,
Schöne C, Altrock WD, Marini C, Frischknecht R, Schanze D, Zenker
M, Gundelfinger ED and Fejtova A: Synaptic activity controls
localization and function of Ct BP 1 via binding to B assoon and P
iccolo. EMBO J. 34:1056–1077. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Thyss R, Virolle V, Imbert V, Peyron JF,
Aberdam D and Virolle T: NF-κB/Egr-1/Gadd45 are sequentially
activated upon UVB irradiation to mediate epidermal cell death.
EMBO J. 24:128–137. 2005. View Article : Google Scholar
|
|
39
|
Rössler OG and Thiel G: Thrombin induces
Egr-1 expression in fibroblasts involving elevation of the
intracellular Ca2+ concentration, phosphorylation of ERK and
activation of ternary complex factor. BMC Mol Biol. 10:402009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mayer SI, Willars GB, Nishida E and Thiel
G: Elk-1, CREB, and MKP-1 regulate Egr-1 expression in
gonadotropin-releasing hormone stimulated gonadotrophs. J Cell
Biochem. 105:1267–1278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Simo-Cheyou ER, Tan JJ, Grygorczyk R and
Srivastava AK: STIM-1 and ORAI-1 channel mediate
angiotensin-II-induced expression of Egr-1 in vascular smooth
muscle cells. J Cell Physiol. 232:3496–3509. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jain N, Mahendran R, Philp R, Guy GR, Tan
YH and Cao X: Casein Kinase II associates with Egr-1 and acts as a
negative modulator of its DNA binding and transcription activities
in NIH 3T3 Cells. J Biol Chem. 271:13530–13536. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Manente AG, Pinton G, Tavian D,
Lopez-Rodas G, Brunelli E and Moro L: Coordinated Sumoylation and
Ubiquitination Modulate EGF Induced EGR1 Expression and Stability.
PLoS One. 6:e256762011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rexach JE, Clark PM and Hsieh-Wilson LC:
Chemical approaches to understanding O-GlcNAc glycosylation in the
brain. Nat Chem Biol. 4:97–106. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cheng D, Dong Z, Lin P, Shen G and Xia Q:
Transcriptional activation of Ecdysone-responsive genes requires
H3K27 acetylation at enhancers. Int J Mol Sci. 23:107912022.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xiong YJ, Zhu Y, Liu YL, Zhao YF, Shen X,
Zuo WQ, Lin F and Liang ZQ: P300 participates in ionizing
Radiation-mediated activation of Cathepsin L by mutant p53. J
Pharmacol Exp Ther. 378:276–286. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wu Z, Huang L, Zhao S, Wang J, Zhang C,
Song X, Chen Q, Du J, Yu D, Sun X, et al: Early growth Response 1
strengthens Pol-III-Directed transcription and transformed cell
proliferation by controlling PTEN/AKT signalling activity. Int J
Mol Sci. 23:49302022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang Y, Yun C, Gao B, Xu Y, Zhang Y, Wang
Y, Kong Q, Zhao F, Wang CR, Dent SYR, et al: The lysine
acetyltransferase GCN5 is required for iNKT cell development
through EGR2 acetylation. Cell Rep. 20:600–612. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Guan X, Deng H, Choi UL, Li Z, Yang Y,
Zeng J, Liu Y, Zhang X and Li G: EZH2 overexpression dampens
tumor-suppressive signals via an EGR1 silencer to drive breast
tumorigenesis. Oncogene. 39:7127–7141. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mendes K, Schmidhofer S, Minderjahn J,
Glatz D, Kiesewetter C, Raithel J, Wimmer J, Gebhard C and Rehli M:
The epigenetic pioneer EGR2 initiates DNA demethylation in
differentiating monocytes at both stable and transient binding
sites. Nat Commun. 12:15562021. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Scheid R, Chen J and Zhong X: Biological
role and mechanism of chromatin readers in plants. Curr Opin Plant
Biol. 61:1020082021. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hu TM, Chen SJ, Hsu SH and Cheng MC:
Functional analyses and effect of DNA methylation on the EGR1 gene
in patients with schizophrenia. Psychiatry Res. 275:276–282. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Salguero-Aranda C, Beltran-Povea A,
Postigo-Corrales F, Hitos AB, Díaz I, Caballano-Infantes E, Fraga
MF, Hmadcha A, Martín F, Soria B, et al: Pdx1 is transcriptionally
regulated by EGR-1 during nitric oxide-induced endoderm
differentiation of mouse embryonic stem cells. Int J Mol Sci.
23:39202022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fetahu IS and Taschner-Mandl S:
Neuroblastoma and the epigenome. Cancer Metastasis Rev. 40:173–189.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Saha SK, Islam SMR, Saha T, Nishat A,
Biswas PK, Gil M, Nkenyereye L, El-Sappagh S, Islam MS and Cho SG:
Prognostic role of EGR1 in breast cancer: A systematic review. BMB
Rep. 54:497–504. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gong Y, Chang C, Liu X, He Y, Wu Y, Wang S
and Zhang C: Stimulator of interferon genes signaling pathway and
its role in Anti-tumor immune therapy. Curr Pharm Des.
26:3085–3095. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yang J, Chen M, Li R, Sun Y, Ye P, Fang K,
Wang C, Shi S and Dong C: A responsive cocktail nano-strategy
breaking the immune excluded state enhances immunotherapy for
triple negative breast cancer. Nanoscale. 17:4610–4623. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yuan H, Qiu C, Wang X, Wang P, Yi L, Peng
X, Xu X, Huang W, Bai Y, Wei J, et al: Engineering semiconducting
polymeric nanoagonists potentiate cGAS-STING pathway activation and
elicit long term memory against recurrence in breast cancer. Adv
Mater. 37:e24066622025. View Article : Google Scholar
|
|
59
|
Hao M, Zhu L, Hou S, Chen S, Li X, Li K,
Zhu N, Chen S, Xue L, Ju C and Zhang C: Sensitizing tumors to
immune checkpoint blockage via STING Agonists delivered by
tumor-penetrating neutrophil cytopharmaceuticals. ACS Nano.
17:1663–1680. 2023. View Article : Google Scholar
|
|
60
|
Noritsugu K, Ito A, Nakao Y and Yoshida M:
Identification of zinc finger transcription factor EGR2 as a novel
acetylated protein. Biochem Biophys Res Commun. 489:455–459. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Stoddart A, Fernald AA, Davis EM, McNerney
ME and Le Beau MM: EGR1 haploinsufficiency confers a fitness
advantage to hematopoietic stem cells following chemotherapy. Exp
Hematol. 115:54–67. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Inoue K and Fry EA: Tumor suppression by
the EGR1, DMP1, ARF, p53, and PTEN network. Cancer Invest.
36:520–536. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Sun T, Zhang Y, Zhong S, Gao F, Chen Y,
Wang B, Cai W, Zhang Z, Li W, Lu S, et al: N-n-Butyl haloperidol
iodide, a derivative of the Anti-psychotic haloperidol, antagonizes
Hypoxia/reoxygenation injury by inhibiting an Egr-1/ROS positive
feedback loop in H9c2 cells. Front Pharmacol. 9:192018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Tseng YC, Shu CW, Chang HM, Lin YH, Tseng
YH, Hsu HS, Goan YG and Tseng CJ: Assessment of early growth
response 1 in tumor suppression of esophageal squamous cell
carcinoma. J Clin Med. 11:57922022. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wang B, Zhang S, Wang H, Wang M, Tao Y, Ye
M, Fan Z, Wang Y and Liu L: Identification of EGR4 as a prospective
target for inhibiting tumor cell proliferation and a novel
biomarker in colorectal cancer. Cancer Gene Ther. 31:871–883. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wang L, Lu J, Song Y, Bai J, Sun W, Yu J,
Cai M and Fu S: Analysis of DNA Repair-related prognostic function
and mechanism in gastric cancer. Front Cell Dev Biol.
10:8970962022. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Sehat B, Andersson S, Vasilcanu R, Girnita
L and Larsson O: Role of Ubiquitination in IGF-1 receptor signaling
and degradation. PLoS One. 2:e3402007. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kuo P, Chen Y, Chen T, Shen K and Hsu Y:
CXCL5/ENA78 increased cell migration and epithelial-to-mesenchymal
transition of hormone-independent prostate cancer by early growth
response-1/snail signaling pathway. J Cell Physiol. 226:1224–1231.
2011. View Article : Google Scholar
|
|
69
|
Xiao D, Chinnappan D, Pestell R, Albanese
C and Weber HC: Bombesin regulates Cyclin D1 expression through the
early growth response protein Egr-1 in prostate cancer cells.
Cancer Res. 65:9934–9942. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yin L, Zhang J and Sun Y: Early growth
response-1 is a new substrate of the GSK3β-FBXW7 axis. Neoplasia.
34:1008392022. View Article : Google Scholar
|
|
71
|
Young E, Noerenberg D, Mansouri L,
Ljungström V, Frick M, Sutton LA, Blakemore SJ, Galan-Sousa J,
Plevova K, Baliakas P, et al: EGR2 mutations define a new
clinically aggressive subgroup of chronic lymphocytic leukemia.
Leukemia. 31:1547–1554. 2017. View Article : Google Scholar
|
|
72
|
Grotegut S, Von Schweinitz D, Christofori
G and Lehembre F: Hepatocyte growth factor induces cell scattering
through MAPK/Egr-1-mediated upregulation of Snail. EMBO J.
25:3534–3545. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wu WS, You RI, Cheng CC, Lee MC, Lin TY
and Hu CT: Author correction: Snail collaborates with EGR-1 and
SP-1 to directly activate transcription of MMP 9 and ZEB1. Sci Rep.
8:142262018. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Yeo H, Lee JY, Kim J, Ahn SS, Jeong JY,
Choi JH, Lee YH and Shin SY: Transcription factor EGR-1
transactivates the MMP1 gene promoter in response to TNFα in HaCaT
keratinocytes. BMB Rep. 53:323–328. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Walcher L, Kistenmacher AK, Suo H, Kitte
R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S and
Kossatz-Boehlert U: Cancer stem cells-origins and biomarkers:
Perspectives for targeted personalized therapies. Front Immunol.
11:12802020. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Sun T, Tian H, Feng YG, Zhu YQ and Zhang
WQ: Egr-1 promotes cell proliferation and invasion by increasing
β-Catenin expression in gastric cancer. Dig Dis Sci. 58:423–430.
2012.
|
|
77
|
Cheng JC, Chang HM and Leung PC: Egr-1
mediates epidermal growth factor-induced downregulation of
E-cadherin expression via Slug in human ovarian cancer cells.
Oncogene. 32:1041–1049. 2013. View Article : Google Scholar
|
|
78
|
Wang Y, Qin C, Zhao B, Li Z, Li T, Yang X,
Zhao Y and Wang W: EGR1 induces EMT in pancreatic cancer via a
P300/SNAI2 pathway. J Transl Med. 21:2012023. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Chen H, Kuo T, Tseng CF, Ma JT, Yang ST,
Yen CJ, Yang CY, Sung SY and Su JL: Angiopoietin-like protein 1
antagonizes MET receptor activity to repress sorafenib resistance
and cancer stemness in hepatocellular carcinoma. Hepatology.
64:1637–1651. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Yang W, Nam K, Ju J, Lee K, Oh S and Shin
I: S100A4 negatively regulates β-catenin by inducing the
Egr-1-PTEN-Akt-GSK3β degradation pathway. Cell Signal.
26:2096–2106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wang C, Ji J, Jin Y, Sun Y, Cai Q, Jiang
J, Guo L, Zhou C and Zhang J: Tumor-mesothelium HOXA11-PDGF BB/TGF
β1-miR-181a-5p-Egr1 feedforward amplifier circuity propels
mesothelial fibrosis and peritoneal metastasis of gastric cancer.
Oncogene. 43:171–188. 2024. View Article : Google Scholar
|
|
82
|
Feng YH, Su YC, Lin SF, Lin PR, Wu CL,
Tung CL, Li CF, Shieh GS and Shiau AL: Oct4 upregulates osteopontin
via Egr1 and is associated with poor outcome in human lung cancer.
BMC Cancer. 19:7912019. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Raue F and Frank-Raue K: Thyroid cancer:
Risk-stratified management and individualized therapy. Clin Cancer
Res. 22:5012–5021. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Ma C, Zhang N, Wang T, Guan H, Huang Y,
Huang L, Zheng Y, Zhang L, Han L, Huo Y, et al: Inflammatory
cytokine-regulated LNCPTCTS suppresses thyroid cancer progression
via enhancing Snail nuclear export. Cancer Lett. 575:2164022023.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Brown KC, Lau JK, Dom AM, Witte TR, Luo H,
Crabtree CM, Shah YH, Shiflett BS, Marcelo AJ, Proper NA, et al:
MG624, an α7-nAChR antagonist, inhibits angiogenesis via the
Egr-1/FGF2 pathway. Angiogenesis. 15:99–114. 2012. View Article : Google Scholar
|
|
86
|
Sperandio S, Fortin J, Sasik R, Robitaille
L, Corbeil J and De Belle I: The transcription factor Egr1
regulates the HIF-1α gene during hypoxia. Mol Carcinog. 48:38–44.
2009. View Article : Google Scholar
|
|
87
|
Shimoyamada H, Yazawa T, Sato H, Okudela
K, Ishii J, Sakaeda M, Kashiwagi K, Suzuki T, Mitsui H, Woo T, et
al: Early growth Response-1 induces and enhances vascular
endothelial growth Factor-A expression in lung cancer cells. Am J
Pathol. 177:70–83. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Yan J, Gao Y, Lin S, Li Y, Shi L and Kan
Q: EGR1-CCL2 feedback loop maintains Epithelial-mesenchymal
transition of Cisplatin-resistant gastric cancer cells and promotes
tumor angiogenesis. Dig Dis Sci. 67:3702–3713. 2022. View Article : Google Scholar
|
|
89
|
Yu J, Zhuang A, Gu X, Hua Y, Yang L, Ge S,
Ruan J, Chai P, Jia R and Fan X: Nuclear PD-L1 promotes
EGR1-mediated angiogenesis and accelerates tumorigenesis. Cell
Discov. 9:332023. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
McCaffrey TA, Fu C, Du B, Eksinar S, Kent
KC, Bush H Jr, Kreiger K, Rosengart T, Cybulsky MI, Silverman ES
and Collins T: High-level expression of Egr-1 and Egr-1-inducible
genes in mouse and human atherosclerosis. J Clin Invest.
105:653–662. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Harja E, Bucciarelli LG, Lu Y, Stern DM,
Zou YS, Schmidt AM and Yan SF: Early growth Response-1 promotes
atherogenesis: Mice deficient in early growth Response-1 and
apolipoprotein E display decreased atherosclerosis and vascular
inflammation. Circ Res. 94:333–339. 2004. View Article : Google Scholar
|
|
92
|
Yan SF, Fujita T, Lu J, Okada K, Shan Zou
Y, Mackman N, Pinsky DJ and Stern DM: Egr-1, a master switch
coordinating upregulation of divergent gene families underlying
ischemic stress. Nat Med. 6:1355–1361. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Suehiro J, Hamakubo T, Kodama T, Aird WC
and Minami T: Vascular endothelial growth factor activation of
endothelial cells is mediated by early growth response-3. Blood.
115:2520–2532. 2010. View Article : Google Scholar :
|
|
94
|
Minami T, Miura M, Aird WC and Kodama T:
Thrombin-induced autoinhibitory factor, down syndrome critical
Region-1, attenuates NFAT-dependent vascular cell adhesion
Molecule-1 expression and inflammation in the endothelium. J Biol
Chem. 281:20503–20520. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Minami T, Horiuchi K, Miura M, Abid MR,
Takabe W, Noguchi N, Kohro T, Ge X, Aburatani H, Hamakubo T, et al:
Vascular endothelial growth Factor- and Thrombin-induced
termination factor, down syndrome critical Region-1, attenuates
endothelial cell proliferation and angiogenesis. J Biol Chem.
279:50537–50554. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Sambasivan S: Epithelial ovarian cancer:
Review article. Cancer Treat Res Commun. 33:1006292022. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
De Belle I, Huang RP, Fan Y, Liu C,
Mercola D and Adamson ED: p53 and Egr-1 additively suppress
transformed growth in HT1080 cells but Egr-1 counteracts
p53-dependent apoptosis. Oncogene. 18:3633–3642. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Ryu J, Choe SS, Ryu SH, Park EY, Lee BW,
Kim TK, Ha CH and Lee SW: Paradoxical induction of growth arrest
and apoptosis by EGF via the up-regulation of PTEN by activating
Redox factor-1/Egr-1 in human lung cancer cells. Oncotarget.
8:4181–4195. 2017. View Article : Google Scholar :
|
|
99
|
Wang C, Husain K, Zhang A, Centeno BA,
Chen DT, Tong Z, Sebti SM and Malafa MP: EGR-1/Bax pathway plays a
role in vitamin E δ-tocotrienol-induced apoptosis in pancreatic
cancer cells. J Nutr Biochem. 26:797–807. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Tian X, Traub B, Shi J, Huber N, Schreiner
S, Chen G, Zhou S, Henne-Bruns D, Knippschild U and Kornmann M:
c-Jun N-terminal kinase 2 suppresses pancreatic cancer growth and
invasion and is opposed by c-Jun N-terminal kinase 1. Cancer Gene
Ther. 29:73–86. 2022. View Article : Google Scholar :
|
|
101
|
Moorehead RA, Hojilla CV, De Belle I, Wood
GA, Fata JE, Adamson ED, Watson KL, Edwards DR and Khokha R:
Insulin-like Growth Factor-II regulates PTEN expression in the
mammary gland. J Biol Chem. 278:50422–50427. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Shan LN, Song YG, Su D, Liu YL, Shi XB and
Lu SJ: Early growth response Protein-1 involves in transforming
growth factor-β1 induced Epithelial-mesenchymal transition and
inhibits migration of Non-Small-cell lung cancer cells. Asian Pac J
Cancer Prev. 16:4137–4142. 2015. View Article : Google Scholar
|
|
103
|
Wang B, Wang Y, Wang W, Wang Z, Zhang Y,
Pan X, Wen X, Leng H, Guo J and Ma XX: WTAP/IGF2BP3 mediated m6A
modification of the EGR1/PTEN axis regulates the malignant
phenotypes of endometrial cancer stem cells. J Exp Clin Cancer Res.
43:2042024. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Unoki M and Nakamura Y: Growth-suppressive
effects of BPOZ and EGR2, two genes involved in the PTEN signaling
pathway. Oncogene. 20:4457–4465. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Unoki M and Nakamura Y: EGR2 induces
apoptosis in various cancer cell lines by direct transactivation of
BNIP3L and BAK. Oncogene. 22:2172–2185. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Chen YL, Lin PC, Chen SP, Lin CC, Tsai NM,
Cheng YL, Chang WL, Lin SZ and Harn HJ: Activation of nonsteroidal
Anti-inflammatory Drug-activated Gene-1 via extracellular
Signal-regulated kinase 1/2 Mitogen-Activated protein kinase
revealed a isochaihulactone-triggered apoptotic pathway in human
lung cancer A549 cells. J Pharmacol Exp Ther. 323:746–756. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Vaish V, Piplani H, Rana C, Vaiphei K and
Sanyal SN: NSAIDs may regulate EGR-1-mediated induction of reactive
oxygen species and non-steroidal anti-inflammatory drug-induced
gene (NAG)-1 to initiate intrinsic pathway of apoptosis for the
chemoprevention of colorectal cancer. Mol Cell Biochem. 378:47–64.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Liu Y, Su Z, Tavana O and Gu W:
Understanding the complexity of p53 in a new era of tumor
suppression. Cancer Cell. 42:946–967. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Ko H, Kim JM, Kim SJ, Shim SH, Ha CH and
Chang HI: Induction of apoptosis by genipin inhibits cell
proliferation in AGS human gastric cancer cells via Egr1/p21
signaling pathway. Bioorg Med Chem Letts. 25:4191–4196. 2015.
View Article : Google Scholar
|
|
110
|
Liu J, Grogan L, Nau M, Allegra C, Chu E
and Wright J: Physical interaction between p53 and primary response
gene Egr-1. Int J Oncol. 18:863–870. 2001.PubMed/NCBI
|
|
111
|
Meng W, Yu S, Li Y, Wang H, Feng Y, Sun W,
Liu Y, Sun S and Liu H: Mutant p53 achieves function by regulating
EGR1 to induce epithelial mesenchymal transition. Tissue Cell.
90:1025102024. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Ahmed MM, Sells SF, Venkatasubbarao K,
Fruitwala SM, Muthukkumar S, Harp C, Mohiuddin M and Rangnekar VM:
Ionizing Radiation-inducible apoptosis in the absence of p53 linked
to transcription factor EGR-1. J Biol Chem. 272:33056–33061. 1997.
View Article : Google Scholar
|
|
113
|
Adams PD: Healing and hurting: Molecular
mechanisms, functions, and pathologies of cellular senescence. Mol
Cell. 36:2–14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Serrano M, Lin AW, McCurrach ME, Beach D
and Lowe SW: Oncogenic ras provokes premature cell senescence
associated with accumulation of p53 and p16INK4a. Cell. 88:593–602.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Salotti J, Sakchaisri K, Tourtellotte WG
and Johnson PF: An Arf-Egr-C/EBPβ pathway linked to Ras-induced
senescence and cancer. Mol Cell Biol. 35:866–883. 2015. View Article : Google Scholar :
|
|
116
|
Lucerna M, Pomyje J, Mechtcheriakova D,
Kadl A, Gruber F, Bilban M, Sobanov Y, Schabbauer G, Breuss J,
Wagner O, et al: Sustained expression of early growth response
Protein-1 blocks angiogenesis and tumor growth. Cancer Res.
66:6708–6713. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Liu M, Wang X, Peng Y, Shen S and Li G:
Egr-1 regulates the transcription of NGX6 gene through a Sp1/Egr-1
overlapping site in the promoter. BMC Mol Biol. 15:142014.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Wang LF, Liu YS, Yang B, Li P, Cheng XS,
Xiao CX, Liu JJ, Li S, Ren JL and Guleng B: The extracellular
matrix protein mindin attenuates colon cancer progression by
blocking angiogenesis via Egr-1-mediated regulation. Oncogene.
37:601–615. 2018. View Article : Google Scholar
|
|
119
|
Kim J, Kang SM, Lee HJ, Choi SY and Hong
SH: Oxytocin inhibits head and neck squamous cell carcinoma cell
migration by early growth response-1 upregulation. Anticancer
Drugs. 28:613–622. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Liu P, Li J, Lu H and Xu B: Thalidomide
inhibits leukemia cell invasion and migration by upregulation of
early growth response gene 1. Leuk Lymphoma. 50:109–113. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Huang R, Li S, Yang W, Chen L, Yao C and
Huang RP: Early growth Response-1 suppresses human fibrosarcoma
cell invasion and angiogenesis. Cancer Genomics Proteomics.
3:71–82. 2006.PubMed/NCBI
|
|
122
|
Mookerjee-Basu J, Hooper R, Gross S,
Schultz B, Go CK, Samakai E, Ladner J, Nicolas E, Tian Y, Zhou B,
et al: Suppression of Ca2+ signals by EGR 4 controls Th1
differentiation and anti-cancer immunity in vivo. EMBO Rep.
21:e489042020. View Article : Google Scholar
|
|
123
|
Zheng Y, Zha Y, Spaapen RM, Mathew R, Barr
K, Bendelac A and Gajewski TF: Egr2-dependent gene expression
profiling and ChIP-Seq reveal novel biologic targets in T cell
anergy. Mol Immunol. 55:283–291. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Williams JB, Horton BL, Zheng Y, Duan Y,
Powell JD and Gajewski TF: The EGR2 targets LAG-3 and 4-1BB
describe and regulate dysfunctional antigen-specific CD8+ T cells
in the tumor microenvironment. J Exp Med. 214:381–400. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Zheng Y, Zha Y, Driessens G, Locke F and
Gajewski TF: Transcriptional regulator early growth response gene 2
(Egr2) is required for T cell anergy in vitro and in vivo. J Exp
Med. 209:2157–2163. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Crispín JC and Tsokos GC: Transcriptional
regulation of IL-2 in health and autoimmunity. Autoimmun Rev.
8:190–195. 2009. View Article : Google Scholar :
|
|
127
|
Decker EL: Early growth response proteins
(EGR) and nuclear factors of activated T cells (NFAT) form
heterodimers and regulate proinflammatory cytokine gene expression.
Nucleic Acids Res. 31:911–921. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Lin JX and Leonard WJ: The immediate-early
gene product Egr-1 regulates the human interleukin-2 receptor
beta-chain promoter through noncanonical Egr and Sp1 binding sites.
Mol Cell Biol. 17:3714–3722. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Lindgren H, Axcrona K and Leanderson T:
Regulation of transcriptional activity of the murine CD40 Ligand
promoter in response to signals through TCR and the costimulatory
molecules CD28 and CD2. J Immunol. 166:4578–4585. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Cron RQ, Bandyopadhyay R, Genin A, Brunner
M, Kersh GJ, Yin J, Finkel TH and Crow MK: Early growth Response-1
is required for CD154 transcription. J Immunol. 176:811–818. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Wherry EJ, Ha SJ, Kaech SM, Haining WN,
Sarkar S, Kalia V, Subramaniam S, Blattman JN, Barber DL and Ahmed
R: Molecular signature of CD8+ T cell exhaustion during chronic
viral infection. Immunity. 27:670–684. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Sen DR, Kaminski J, Barnitz RA, Kurachi M,
Gerdemann U, Yates KB, Tsao HW, Godec J, LaFleur MW, Brown FD, et
al: The epigenetic landscape of T cell exhaustion. Science.
354:1165–1169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Man K, Gabriel SS, Liao Y, Gloury R,
Preston S, Henstridge DC, Pellegrini M, Zehn D, Berberich-Siebelt
F, Febbraio MA, et al: Transcription factor IRF4 Promotes CD8+ T
cell exhaustion and limits the development of Memory-like T cells
during chronic infection. Immunity. 47:1129–1141.e5. 2017.
View Article : Google Scholar
|
|
134
|
Doering TA, Crawford A, Angelosanto JM,
Paley MA, Ziegler CG and Wherry EJ: Network analysis reveals
centrally connected genes and pathways involved in CD8+ T cell
exhaustion versus memory. Immunity. 37:1130–1144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Kallies A, Zehn D and Utzschneider DT:
Precursor exhausted T cells: Key to successful immunotherapy? Nat
Rev Immunol. 20:128–136. 2020. View Article : Google Scholar
|
|
136
|
Macián F, Garcı́a-Cózar F, Im SH, Horton
HF, Byrne MC and Rao A: Transcriptional mechanisms underlying
lymphocyte tolerance. Cell. 109:719–731. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Martinez GJ, Pereira RM, Äijö T, Kim EY,
Marangoni F, Pipkin ME, Togher S, Heissmeyer V, Zhang YC, Crotty S,
et al: The transcription factor NFAT promotes exhaustion of
activated CD8 + T Cells. Immunity. 42:265–278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Mittelstadt PR and Ashwell JD: Cyclosporin
A-Sensitive transcription factor Egr-3 regulates fas ligand
expression. Mol Cell Biol. 18:3744–3751. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Safford M, Collins S, Lutz MA, Allen A,
Huang CT, Kowalski J, Blackford A, Horton MR, Drake C, Schwartz RH
and Powell JD: Egr-2 and Egr-3 are negative regulators of T cell
activation. Nat Immunol. 6:472–480. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Rengarajan J, Mittelstadt PR, Mages HW,
Gerth AJ, Kroczek RA, Ashwell JD and Glimcher LH: Sequential
Involvement of NFAT and Egr transcription factors in FasL
regulation. Immunity. 12:293–300. 2000. View Article : Google Scholar
|
|
141
|
Kodakandla G, Akimzhanov AM and Boehning
D: Regulatory mechanisms controlling store-operated calcium entry.
Front Physiol. 14:13302592023. View Article : Google Scholar
|
|
142
|
Kim HJ, Park S, Shin HY, Nam YR, Lam Hong
PT, Chin YW, Nam JH and Kim WK: Inhibitory effects of α-Mangostin
on T cell cytokine secretion via ORAI1 calcium channel and
K+ channels inhibition. PeerJ. 9:e109732021. View Article : Google Scholar
|
|
143
|
Srikanth S, Woo JS, Sun Z and Gwack Y:
Immunological disorders: Regulation of Ca2+ signaling in
T lymphocytes. Adv Exp Med Biol. 993:397–424. 2017. View Article : Google Scholar
|
|
144
|
Gross S, Womer L, Kappes DJ and Soboloff
J: Multifaceted control of T cell differentiation by STIM1. Trends
Biochem Sci. 48:1083–1097. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Thompson JL, Lai-Zhao Y, Stathopulos PB,
Grossfield A and Shuttleworth TJ: Phosphorylation-mediated
structural changes within the SOAR domain of stromal interaction
molecule 1 enable specific activation of distinct Orai channels. J
Biol Chem. 293:3145–3155. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Flourakis M, Lehen'kyi V, Beck B, Raphaël
M, Vandenberghe M, Abeele FV, Roudbaraki M, Lepage G, Mauroy B,
Romanin C, et al: Orai1 contributes to the establishment of an
apoptosis-resistant phenotype in prostate cancer cells. Cell Death
Dis. 1:e752010. View Article : Google Scholar
|
|
147
|
Xie J, Pan H, Yao J, Zhou Y and Han W:
SOCE and cancer: Recent progress and new perspectives. Int J
Cancer. 138:2067–2077. 2016. View Article : Google Scholar :
|
|
148
|
Im SJ, Hashimoto M, Gerner MY, Lee J,
Kissick HT, Burger MC, Shan Q, Hale JS, Lee J, Nasti TH, et al:
Defining CD8+ T cells that provide the proliferative burst after
PD-1 therapy. Nature. 537:417–421. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Armesilla AL, Lorenzo E, Gómez Del Arco P,
Martínez-Martínez S, Alfranca A and Redondo JM: Vascular
Endothelial growth factor activates nuclear factor of activated T
cells in human endothelial cells: A role for tissue factor gene
expression. Mol Cell Biol. 19:2032–2043. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Chen YF, Chiu WT, Chen YT, Lin PY, Huang
HJ, Chou CY, Chang HC, Tang MJ and Shen MR: Calcium store sensor
stromal-interaction molecule 1-dependent signaling plays an
important role in cervical cancer growth, migration, and
angiogenesis. Proc Natl Acad Sci USA. 108:15225–15230. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Xu Y, Zhang S, Niu H, Ye Y, Hu F, Chen S,
Li X, Luo X, Jiang S, Liu Y, et al: STIM1 accelerates cell
senescence in a remodeled microenvironment but enhances the
epithelial-to-mesenchymal transition in prostate cancer. Sci Rep.
5:117542015. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Yang S, Zhang JJ and Huang XY: Orai1 and
STIM1 are critical for breast tumor cell migration and metastasis.
Cancer Cell. 15:124–134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Wilm B and Muñoz-Chapuli R: The role of
WT1 in Embryonic Development and Normal Organ Homeostasis. The
Wilms' Tumor (WT1) Gene. 1467. Hastie N: Springer New York; New
York, NY: pp. 23–39. 2016, View Article : Google Scholar
|
|
154
|
Madden SL, Cook DM, Morris JF, Gashler A,
Sukhatme VP and Rauscher FJ: Transcriptional repression mediated by
the WT1 wilms tumor gene product. Science. 253:1550–1553. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Zandarashvili L, White MA, Esadze A and
Iwahara J: Structural impact of complete CpG methylation within
target DNA on specific complex formation of the inducible
transcription factor Egr-1. FEBS Lett. 589:1748–1753. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Hashimoto H, Olanrewaju YO, Zheng Y,
Wilson GG, Zhang X and Cheng X: Wilms tumor protein recognizes
5-carboxylcytosine within a specific DNA sequence. Genes Dev.
28:2304–2313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Eleftheriou M, Pascual AJ, Wheldon LM,
Perry C, Abakir A, Arora A, Johnson AD, Auer DT, Ellis IO,
Madhusudan S and Ruzov A: 5-Carboxylcytosine levels are elevated in
human breast cancers and gliomas. Clin Epigenet. 7:882015.
View Article : Google Scholar
|
|
158
|
Neri F, Incarnato D, Krepelova A, Rapelli
S, Anselmi F, Parlato C, Medana C, Dal Bello F and Oliviero S:
Single-base resolution analysis of 5-formyl and 5-carboxyl cytosine
reveals promoter DNA methylation dynamics. Cell Rep. 10:674–683.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Ritchie MF, Yue C, Zhou Y, Houghton PJ and
Soboloff J: Wilms tumor suppressor 1 (WT1) and early growth
response 1 (EGR1) are regulators of STIM1 expression. J Biol Chem.
285:10591–10596. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Natrajan R, Little SE, Reis-Filho JS, Hing
L, Messahel B, Grundy PE, Dome JS, Schneider T, Vujanic GM,
Pritchard-Jones K and Jones C: Amplification and overexpression of
CACNA1E correlates with relapse in favorable histology Wilms'
tumors. Clinical Cancer Res. 12:7284–7293. 2006. View Article : Google Scholar
|
|
161
|
Wittmann S, Wunder C, Zirn B, Furtwängler
R, Wegert J, Graf N and Gessler M: New prognostic markers revealed
by evaluation of genes correlated with clinical parameters in Wilms
tumors. Genes Chromosomes Cancer. 47:386–395. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Wagle MV, Vervoort SJ, Kelly MJ, Van Der
Byl W, Peters TJ, Martin BP, Martelotto LG, Nüssing S, Ramsbottom
KM, Torpy JR, et al: Antigen-driven EGR2 expression is required for
exhausted CD8+ T cell stability and maintenance. Nat Commun.
12:27822021. View Article : Google Scholar :
|
|
163
|
Lee J, Lee K, Bae H, Lee K, Lee S, Ma J,
Jo K, Kim I, Jee B, Kang M and Im SJ: IL-15 promotes self-renewal
of progenitor exhausted CD8 T cells during persistent antigenic
stimulation. Front Immunol. 14:11170922023. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Sun L, Ma Z, Zhao X, Tan X, Tu Y, Wang J,
Chen L, Chen Z, Chen G and Lan P: LRP11 promotes stem-like T cells
via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1
immunotherapy. J Immunother Cancer. 12:e0083672024. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Omodho B, Miao T, Symonds ALJ, Singh R, Li
S and Wang P: Transcription factors early growth response gene
(Egr) 2 and 3 control inflammatory responses of tolerant T cells.
Immun Inflamm Dis. 6:221–233. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Liu Y, Debo B, Li M, Shi Z, Sheng W and
Shi Y: Author correction: LSD1 inhibition sustains T cell
invigoration with a durable response to PD-1 blockade. Nat Commun.
13:2632022. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Symonds ALJ, Miao T, Busharat Z, Li S and
Wang P: Egr2 and 3 maintain anti-tumour responses of exhausted
tumour infiltrating CD8 + T cells. Cancer Immunol Immunother.
72:1139–1151. 2023. View Article : Google Scholar
|
|
168
|
Symonds AL, Zheng W, Miao T, Wang H, Wang
T, Kiome R, Hou X, Li S and Wang P: Egr2 and 3 control
inflammation, but maintain homeostasis, of PD-1high
memory phenotype CD4 T cells. Life Sci Alliance. 3:e2020007662020.
View Article : Google Scholar
|
|
169
|
Miao T, Symonds ALJ, Singh R, Symonds JD,
Ogbe A, Omodho B, Zhu B, Li S and Wang P: Egr2 and 3 control
adaptive immune responses by temporally uncoupling expansion from T
cell differentiation. J Exp Med. 214:1787–1808. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Seyfert VL, McMahon SB, Glenn WD, Yellen
AJ, Sukhatme VP, Cao X and Monroe JG: Methylation of an
Immediate-early inducible gene as a mechanism for B cell tolerance
induction. Science. 250:797–800. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Natarajan P, Singh A, McNamara JT, Secor
ER, Guernsey LA, Thrall RS and Schramm CM: Regulatory B cells from
hilar lymph nodes of tolerant mice in a murine model of allergic
airway disease are CD5+, express TGF-β, and co-localize with
CD4+Foxp3+ T cells. Mucosal Immunol. 5:691–701. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Matsumoto M, Baba A, Yokota T, Nishikawa
H, Ohkawa Y, Kayama H, Kallies A, Nutt SL, Sakaguchi S, Takeda K,
et al: Interleukin-10-Producing plasmablasts exert regulatory
function in autoimmune inflammation. Immunity. 41:1040–1051. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Xie J, Shi CW, Huang HB, Yang WT, Jiang
YL, Ye LP, Zhao Q, Yang GL and Wang CF: Induction of the
IL-10-producing regulatory B cell phenotype following Trichinella
spiralis infection. Mol Immunol. 133:86–94. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Nguyen HQ, Hoffman-Liebermann B and
Liebermann DA: The zinc finger transcription factor Egr-1 is
essential for and restricts differentiation along the macrophage
lineage. Cell. 72:197–209. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Kharbanda S, Nakamura T, Stone R, Hass R,
Bernstein S, Datta R, Sukhatme VP and Kufe D: Expression of the
early growth response 1 and 2 zinc finger genes during induction of
monocytic differentiation. J Clin Invest. 88:571–577. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Laslo P, Spooner CJ, Warmflash A, Lancki
DW, Lee HJ, Sciammas R, Gantner BN, Dinner AR and Singh H:
Multilineage transcriptional priming and determination of alternate
hematopoietic cell fates. Cell. 126:755–766. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Carter JH and Tourtellotte WG: Early
growth response transcriptional regulators are dispensable for
macrophage differentiation. J Immunol. 178:3038–3047. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Pham TH, Benner C, Lichtinger M,
Schwarzfischer L, Hu Y, Andreesen R, Chen W and Rehli M: Dynamic
epigenetic enhancer signatures reveal key transcription factors
associated with monocytic differentiation states. Blood.
119:e161–e171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Trizzino M, Zucco A, Deliard S, Wang F,
Barbieri E, Veglia F, Gabrilovich D and Gardini A: EGR1 is a
gatekeeper of inflammatory enhancers in human macrophages. Sci Adv.
7:eaaz88362021. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Ponomarev ED, Shriver LP, Maresz K,
Pedras-Vasconcelos J, Verthelyi D and Dittel BN: GM-CSF production
by autoreactive T cells is required for the activation of
microglial cells and the onset of experimental autoimmune
encephalomyelitis. J Immunol. 178:39–48. 2007. View Article : Google Scholar
|
|
181
|
Murray PJ: Macrophage Polarization. Annu
Rev Physiol. 79:541–566. 2017. View Article : Google Scholar
|
|
182
|
Italiani P and Boraschi D: From monocytes
to M1/M2 macrophages: Phenotypical vs. functional differentiation.
Front Immunol. 5:5142014. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Jablonski KA, Amici SA, Webb LM,
Ruiz-Rosado JDD, Popovich PG, Partida-Sanchez S and
Guerau-de-Arellano M: Novel Markers to delineate murine M1 and M2
macrophages. PLoS One. 10:e01453422015. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Horvath A, Daniel B, Szeles L,
Cuaranta-Monroy I, Czimmerer Z, Ozgyin L, Steiner L, Kiss M,
Simandi Z, Poliska S, et al: Labelled regulatory elements are
pervasive features of the macrophage genome and are dynamically
utilized by classical and alternative polarization signals. Nucleic
Acids Res. 47:2778–2792. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Daniel B, Nagy G, Horvath A, Czimmerer Z,
Cuaranta-Monroy I, Poliska S, Hays TT, Sauer S, Francois-Deleuze J
and Nagy L: The IL-4/STAT6/PPARγ signaling axis is driving the
expansion of the RXR heterodimer cistrome, providing complex ligand
responsiveness in macrophages. Nucleic Acids Res. 46:4425–4439.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Daniel B, Nagy G, Czimmerer Z, Horvath A,
Hammers DW, Cuaranta-Monroy I, Poliska S, Tzerpos P, Kolostyak Z,
Hays TT, et al: The nuclear receptor PPARγ controls progressive
macrophage polarization as a Ligand-insensitive epigenomic ratchet
of transcriptional memory. Immunity. 49:615–626.e6. 2018.
View Article : Google Scholar
|
|
187
|
Szanto A, Balint BL, Nagy ZS, Barta E,
Dezso B, Pap A, Szeles L, Poliska S, Oros M, Evans RM, et al: STAT6
transcription factor is a facilitator of the nuclear receptor
PPARγ-regulated gene expression in macrophages and dendritic cells.
Immunity. 33:699–712. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Czimmerer Z, Daniel B, Horvath A, Rückerl
D, Nagy G, Kiss M, Peloquin M, Budai MM, Cuaranta-Monroy I, Simandi
Z, et al: The transcription factor STAT6 mediates direct repression
of inflammatory enhancers and limits activation of alternatively
polarized macrophages. Immunity. 48:75–90.e6. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Piccolo V, Curina A, Genua M, Ghisletti S,
Simonatto M, Sabò A, Amati B, Ostuni R and Natoli G: Opposing
macrophage polarization programs show extensive epigenomic and
transcriptional cross-talk. Nat Immunol. 18:530–540. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Sabag B, Puthenveetil A, Levy M, Joseph N,
Doniger T, Yaron O, Karako-Lampert S, Lazar I, Awwad F, Ashkenazi S
and Barda-Saad M: Dysfunctional natural killer cells can be
reprogrammed to regain anti-tumor activity. EMBO J. 43:2552–2581.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Zhang W, Tong H, Zhang Z, Shao S, Liu D,
Li S and Yan Y: Transcription factor EGR1 promotes differentiation
of bovine skeletal muscle satellite cells by regulating MyoG gene
expression. J Cell Physiol. 233:350–362. 2018. View Article : Google Scholar
|
|
192
|
Wei S, Xu G, Zhao S, Zhang C, Feng Y, Yang
W, Lu R, Zhou J and Ma Y: EGR2 promotes liver cancer metastasis by
enhancing IL-8 expression through transcription regulation of PDK4
in M2 macrophages. Int Immunopharmacol. 153:1144842025. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Zhang S, Tao X, Cao Q, Feng X, Wu J, Yu H,
Yu Y, Xu C and Zhao H: lnc003875/miR-363/EGR1 regulatory network in
the carcinoma-associated fibroblasts controls the angiogenesis of
human placental site trophoblastic tumor (PSTT). Exp Cell Res.
387:1117832020. View Article : Google Scholar
|
|
194
|
Zhang Y, Sun S, Qi Y, Dai Y, Hao Y, Xin M,
Xu R, Chen H, Wu X, Liu Q, et al: Characterization of tumour
microenvironment reprogramming reveals invasion in epithelial
ovarian carcinoma. J Ovarian Res. 16:2002023. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Joo EH, Bae JH, Park J, Bang YJ, Han J,
Gulati N, Kim JI, Park CG, Park WY and Kim HJ: Deconvolution of
adult T-Cell Leukemia/lymphoma with Single-cell RNA-Seq using
frozen archived skin tissue reveals new subset of Cancer-associated
fibroblast. Front Immunol. 13:8563632022. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Seyfried TN, Flores RE, Poff AM and
D'Agostino DP: Cancer as a metabolic disease: Implications for
novel therapeutics. Carcinogenesis. 35:515–527. 2014. View Article : Google Scholar :
|
|
197
|
Ward PS and Thompson CB: Metabolic
reprogramming: A cancer hallmark even warburg did not anticipate.
Cancer Cell. 21:297–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Li L, Li L, Li W, Chen T, Bin Zou, Zhao L,
Wang H, Wang X, Xu L, Liu X, et al: TAp73-induced
phosphofructokinase-1 transcription promotes the Warburg effect and
enhances cell proliferation. Nat Commun. 9:46832018. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Pan M, Luo M, Liu L, Chen Y, Cheng Z, Wang
K, Huang L, Tang N, Qiu J, Huang A and Xia J: EGR1 suppresses HCC
growth and aerobic glycolysis by transcriptionally downregulating
PFKL. J Exp Clin Cancer Res. 43:352024. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Sulli G, Lam MTY and Panda S: Interplay
between circadian clock and cancer: New frontiers for cancer
treatment. Trends Cancer. 5:475–494. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Zhang R, Lahens NF, Ballance HI, Hughes ME
and Hogenesch JB: A circadian gene expression atlas in mammals:
Implications for biology and medicine. Proc Natl Acad Sci USA.
111:16219–16224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Wu J, Bu D, Wang H, Shen D, Chong D, Zhang
T, Tao W, Zhao M, Zhao Y, Fang L, et al: The rhythmic coupling of
Egr-1 and Cidea regulates age-related metabolic dysfunction in the
liver of male mice. Nat Commun. 14:16342023. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Qu M, Zhang G, Qu H, Vu A, Wu R, Tsukamoto
H, Jia Z, Huang W, Lenz HJ, Rich JN and Kay SA: Circadian regulator
BMAL1::CLOCK promotes cell proliferation in hepatocellular
carcinoma by controlling apoptosis and cell cycle. Proc Natl Acad
Sci USA. 120:e22148291202023. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Spencer RL and Deak T: A users guide to
HPA axis research. Physiol Behav. 178:43–65. 2017. View Article : Google Scholar :
|
|
205
|
Wan X, Wang L, Khan MA, Peng L, Zhang K,
Sun X, Yi X, Wang Z and Chen K: Shift work promotes adipogenesis
via cortisol-dependent downregulation of EGR3-HDAC6 pathway. Cell
Death Discov. 10:1292024. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Deuter CE, Kaczmarczyk M, Hellmann-Regen
J, Kuehl LK, Wingenfeld K and Otte C: The influence of
pharmacological mineralocorticoid and glucocorticoid receptor
blockade on the cortisol response to psychological stress. Prog
Neuropsychopharmacol Biol Psychiatry. 129:1109052024. View Article : Google Scholar
|
|
207
|
Wu K, Liu Z, Liang J, Zhu Y, Wang X and Li
X: Discovery of a glucocorticoid receptor (GR) activity signature
correlates with immune cell infiltration in adrenocortical
carcinoma. J Immunother Cancer. 11:e0075282023. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Pang Y, Gong S, Tetti M, Sun Z,
Mir-Bashiri S, Bidlingmaier M, Knösel T, Wolf E, Reincke M, Kemter
E and Williams TA: EGR1 regulates oxidative stress and aldosterone
production in adrenal cells and aldosterone-producing adenomas.
Redox Biol. 80:1034982025. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Miki Y, Iwabuchi E, Takagi K, Yamazaki Y,
Shibuya Y, Tokunaga H, Shimada M, Suzuki T and Ito K: Intratumoral
cortisol associated with aromatase in the endometrial cancer
microenvironment. Pathol Res Pract. 251:1548732023. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Heyns B, Pieters R, Stander MA, Atkin SL
and Swart AC: Glucocorticoids and mineralocorticoids in hair:
Facilitating accurate diagnosis of adrenal-related endocrine
disorders. Front Endocrinol (Lausanne). 15:14480132024. View Article : Google Scholar : PubMed/NCBI
|
|
211
|
Zhou L, Shan Y, Li J, Li M, Meng Z and Guo
N: Early growth response 1 regulates dual-specificity protein
phosphatase 1 and inhibits cell migration and invasion of tongue
squamous cell carcinoma. Oncol Lett. 27:2402024. View Article : Google Scholar
|
|
212
|
Senga SS and Grose RP: Hallmarks of
cancer-the New testament. Open Biol. 11:2003582021. View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Magnon C, Hall SJ, Lin J, Xue X, Gerber L,
Freedland SJ and Frenette PS: Autonomic nerve development
contributes to prostate cancer progression. Science.
341:12363612013. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Cheng Y, Sun F, D'Souza A, Dhakal B,
Pisano M, Chhabra S, Stolley M, Hari P and Janz S: Autonomic
nervous system control of multiple myeloma. Blood Rev.
46:1007412021. View Article : Google Scholar :
|
|
215
|
Tan X, Sivakumar S, Bednarsch J,
Wiltberger G, Kather JN, Niehues J, de Vos-Geelen J, Valkenburg-van
Iersel L, Kintsler S, Roeth A, et al: Nerve fibers in the tumor
microenvironment in neurotropic cancer-pancreatic cancer and
cholangiocarcinoma. Oncogene. 40:899–908. 2021. View Article : Google Scholar
|
|
216
|
Monje M, Borniger JC, D'Silva NJ, Deneen
B, Dirks PB, Fattahi F, Frenette PS, Garzia L, Gutmann DH, Hanahan
D, et al: Roadmap for the emerging field of cancer neuroscience.
Cell. 181:219–222. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Hayakawa Y, Sakitani K, Konishi M, Asfaha
S, Niikura R, Tomita H, Renz BW, Tailor Y, Macchini M, Middelhoff
M, et al: Nerve growth factor promotes gastric tumorigenesis
through aberrant cholinergic signaling. Cancer Cell. 31:21–34.
2017. View Article : Google Scholar :
|
|
218
|
Regan JL, Schumacher D, Staudte S, Steffen
A, Lesche R, Toedling J, Jourdan T, Haybaeck J, Golob-Schwarzl N,
Mumberg D, et al: Identification of a neural development gene
expression signature in colon cancer stem cells reveals a role for
EGR2 in tumorigenesis. iScience. 25:1044982022. View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Cheng H and Cheng T: 'Waterloo': When
normal blood cells meet leukemia. Curr Opin Hematol. 23:304–310.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Chen CH, Chen Y, Li YN, Zhang H, Huang X,
Li YY, Li ZY, Han JX, Wu XY, Liu HJ and Sun T: EGR3 inhibits tumor
progression by inducing schwann Cell-Like differentiation. Adv Sci
(Weinh). 11:e24000662024. View Article : Google Scholar : PubMed/NCBI
|
|
221
|
Spasevska I, Matera EL, Chettab K, Ville
J, Potier-Cartereau M, Jordheim LP, Thieblemont C, Sahin D, Klein C
and Dumontet C: Calcium channel blockers impair the antitumor
activity of Anti-CD20 monoclonal antibodies by blocking EGR-1
induction. Mol Cancer Ther. 19:2371–2381. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Lim JH, Park JW, Min DS, Chang JS, Lee YH,
Park YB, Choi KS and Kwon TK: NAG-1 up-regulation mediated by EGR-1
and p53 is critical for quercetin-induced apoptosis in HCT116 colon
carcinoma cells. Apoptosis. 12:411–421. 2007. View Article : Google Scholar
|
|
223
|
Shi Q and Bhatia D: Resveratrol-responsive
CArG elements from the Egr-1 promoter for the induction of GADD45α
to arrest the G2/M transition. Suicide Gene Therapy. 1895. Düzgüneş
N: Springer New York; New York, NY: pp. 111–122. 2019, View Article : Google Scholar
|
|
224
|
Shah D, Challagundla N, Dave V, Patidar A,
Saha B, Nivsarkar M, Trivedi VB and Agrawal-Rajput R: Berberine
mediates tumor cell death by skewing tumor-associated
immunosuppressive macrophages to inflammatory macrophages.
Phytomedicine. 99:1539042022. View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Han S, Yang X, Zhuang J, Zhou Q, Wang J,
Ru L, Niu F and Mao W: α-Hederin promotes ferroptosis and reverses
cisplatin chemoresistance in non-small cell lung cancer. Aging.
16:1298–1317. 2024. View Article : Google Scholar
|
|
226
|
Wang W, Li R, Chen Z, Li D, Duan Y and Cao
Z: Cisplatin-controlled p53 gene therapy for human non-small cell
lung cancer xenografts in athymic nude mice via the CArG elements.
Cancer Sci. 96:706–712. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
227
|
Wang Z, Wei B and Ma S:
EGR1/LINC00839/SOX5 axis modulates migration, invasion and
Gemcitabine resistance of bladder cancer cells. Cancer Biol Ther.
24:22701062023. View Article : Google Scholar : PubMed/NCBI
|
|
228
|
Marks BA, Pipia IM, Mukai C, Horibata S,
Rice EJ, Danko CG and Coonrod SA: GDNF-RET signaling and EGR1 form
a positive feedback loop that promotes tamoxifen resistance via
cyclin D1. BMC Cancer. 23:1382023. View Article : Google Scholar : PubMed/NCBI
|
|
229
|
Yang Z, Chen F, Wei D, Chen F, Jiang H and
Qin S: EGR1 mediates MDR1 transcriptional activity regulating
gemcitabine resistance in pancreatic cancer. BMC Cancer.
24:2682024. View Article : Google Scholar : PubMed/NCBI
|
|
230
|
Lin Z, Liu Z, Pan Z, Zhang Y, Yang X, Feng
Y, Zhang R, Zeng W, Gong C and Chen J: EGR1 Promotes
Erastin-induced ferroptosis through activating Nrf2-HMOX1 signaling
pathway in breast cancer cells. J Cancer. 15:4577–4590. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Palencia-Campos A, Ruiz-Cañas L,
Abal-Sanisidro M, López-Gil JC, Batres-Ramos S, Saraiva SM, Yagüe
B, Navarro D, Alcalá S, Rubiolo JA, et al: Reprogramming
tumor-associated macrophages with lipid nanosystems reduces PDAC
tumor burden and liver metastasis. J Nanobiotechnol. 22:7952024.
View Article : Google Scholar
|
|
232
|
Mo Z, Du P, Wang G and Wang Y: The
Multi-purpose tool of tumor immunotherapy: Gene-engineered T cells.
J Cancer. 8:1690–1703. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Xu Y, Yang Z, Horan LH, Zhang P, Liu L,
Zimdahl B, Green S, Lu J, Morales JF, Barrett DM, et al: A novel
antibody-TCR (AbTCR) platform combines Fab-based antigen
recognition with gamma/delta-TCR signaling to facilitate T-cell
cytotoxicity with low cytokine release. Cell Discov. 4:622018.
View Article : Google Scholar : PubMed/NCBI
|
|
234
|
Jung IY, Bartoszek RL, Rech AJ, Collins
SM, Ooi SK, Williams EF, Hopkins CR, Narayan V, Haas NB, Frey NV,
et al: Type I interferon signaling via the EGR2 transcriptional
regulator potentiates CAR T Cell-intrinsic dysfunction. Cancer
Discov. 13:1636–1655. 2023. View Article : Google Scholar : PubMed/NCBI
|
